期刊文献+

Arterial Stiffness as a Cardiovascular Risk Factor in Prostate Cancer Survivors:A Case-Control Study

原文传递
导出
摘要 Purpose In New Zealand,prostate cancer (PCa) is the most commonly diagnosed cancer in men and the third most common cause of male cancer deaths.Among these patients,the most common non-cancer related cause of death is cardiovascular disease (CVD).Aortic arterial stiffness may be clinically viable solution for detecting and tracking CVD risk factor in PCa survivors.The aim of the study was to determine whether aortic arterial stiffness is increased in PCa survivors compared to age-matched controls.Methods Participants recruited for this prospective comparative study were PCa survivors who had completed treatment(other than endocrine therapy) or were on active surveillance compared,or were age-matched non-cancer controls.During a single 1-h appointment,all participants had measures of aortic arterial stiffness,arterial wave reflection,central blood pressure and body composition taken.Results Ninety-eight men were recruited,51 PCa survivors and 47 controls.There was no significant between group dif-ference for aortic arterial stiffness[12.0 m/s (SD:1.7) vs.12.0 m/s (SD:1.9),P=0.953,d=0.0].Fat free mass[60.7 kg(SD:4.9) vs.65.1 kg (SD:8.3),P=0.007,d=0.6]and skeletal muscle index[8.6 kg/m2 (SD:0.6) vs.9.0 kg/m2 (SD:0.9),P=0.050,d=0.5]were lower in the PCa group.Conclusions Aortic arterial stiffness is not increased (worse) in men with PCa who receive various treatments,compared to age-matched controls.These findings may indicate that factors other than increased aortic arterial stiffness contribute to heightened risk of cardiovascular events in this population.
出处 《Journal of Science in Sport and Exercise》 2021年第2期171-178,共8页 体育运动科学(英文)
  • 相关文献

参考文献1

二级参考文献134

  • 1Dacal K, Sereika SM, Greenspan SL. Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc 2006; 54: 85-90.
  • 2Maturo G, Vespasiani G, Mohamed EI, Maiolo C, Finazzi Agro E et al. Evaluating body composition of Italian prostate cancer patients without metastases. Acta Diabetol 02003;Suppl 1,S168-70.
  • 3Sieber PR, Keiller DL, Kahnoski RJ, Gallo J, McFadden S. Bicalutamide 150 mg maintains bone mineral density during rnonotherapy for localized or locally advanced prostate cancer. J Urol 2004; 171: 2272-6, quiz 2435.
  • 4Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H et al. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Clin Oncol 2004; 22: 2546-53.
  • 5Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr2002; 76: 473--81.
  • 6Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-96.
  • 7Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2006; 181: 1998-2006; discussion 2007-8.
  • 8Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer 2008; 16: 987-97.
  • 9Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB,et al. Resistance exercise in men recelving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653-9.
  • 10Culos-Reed SN, Robinson JL, Lau H, O'Connor K, Keats MR. Benefits of a physical activity intervention for men with prostate cancer. J Sport Exerc Psychol 2007; 29: 118-27.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部